首页> 外文期刊>International Journal of Mycobacteriology >Mycobacterium leprae specific genomic target in the promoter region of probable 4-alpha-glucanotransferase (ML1545) gene with potential sensitivity for polymerase chain reaction based diagnosis of leprosy
【24h】

Mycobacterium leprae specific genomic target in the promoter region of probable 4-alpha-glucanotransferase (ML1545) gene with potential sensitivity for polymerase chain reaction based diagnosis of leprosy

机译:可能是4-α-葡萄糖基转移酶(ML1545)基因启动子区域的麻风分枝杆菌特异性基因组靶标,对基于聚合酶链反应的麻风病诊断具有潜在敏感性

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

With the absence of an effective diagnostic tool for leprosy, cases with negative bacteriological index and limited clinical manifestations often pose diagnostic challenges. In this study, we investigated the utility of a novel Mycobacterium leprae specific 112-bp DNA sequence in the promoter region of probable 4-aIpha-glucanotransferase (pseudogene, ML1545) for polymerase chain reaction (PCR) based diagnosis of leprosy in comparison to that of the RLEP gene. DNA was extracted from slit skin scrapings of 180 newly diagnosed untreated leprosy cases that were classified as per Ridley Jopling classifications and bacteriological index (BI). Primers were designed using Primer Blast 3.0 and PCR was performed with annealing temperatures of 61 °C for ML1545 and 58 °C for the RLEP gene using conventional gradient PCR. The results indicated a significant increase in PCR positivity of ML1545 when compared to RLEP across the study groups (164/180 [91.11%] were positive for ML1545 whereas 114/180 (63.33%) were positive for RLEP [p < .0001, z = 6.3]). Among 58 leprosy cases with negative BI, 28 (48.28%) were positive for RLEP and 48 (82.76%) were positive for ML1545 (p = .0001, z = 3.8). Of the 42 borderline tuberculoid leprosy cases, 23 (54.76%) were positive for RLEP whereas 37 (88.09%) were positive for ML1545 (p < .0001, z = 3.9). Increase in PCR positivity for ML1545 was also noted in lepromatous leprosy and Bl-positive groups. ML1545 can be a potential gene target for PCR-based diagnosis of leprosy especially in cases where clinical manifestations were minimal.
机译:由于缺乏有效的麻风病诊断工具,细菌学指标为阴性且临床表现有限的病例通常会带来诊断挑战。在这项研究中,我们调查了一种新的麻风分枝杆菌特异性112 bp DNA序列在可能的4-α-α-葡糖基转移酶(假基因,ML1545)的启动子区域用于基于聚合酶链反应(PCR)的麻风病诊断的实用性。 RLEP基因。从180例新诊断的未经治疗的麻风病例的狭缝皮肤刮取物中提取DNA,这些病例根据Ridley Jopling分类和细菌学指数(BI)分类。使用Primer Blast 3.0设计引物,对于ML1545,PCR的退火温度为61°C,对于RLEP基因,PCR的退火温度为58°C,采用常规梯度PCR。结果表明,在整个研究组中,与RLEP相比,ML1545的PCR阳性率显着增加(ML1545阳性为164/180 [91.11%],而RLEP阳性为114/180(63.33%)[p <.0001,z = 6.3])。在58例BI阴性的麻风病患者中,RLEP阳性28例(48.28%),而ML1545阳性48例(82.76%)(p = .0001,z = 3.8)。在42例交界性结核麻风病例中,RLEP阳性23例(54.76%),而ML1545阳性37例(88.09%)(p <.0001,z = 3.9)。在麻风麻风病和B1阳性组中,ML1545的PCR阳性也有所增加。 ML1545可能是基于PCR的麻风病诊断的潜在基因靶标,特别是在临床表现很少的情况下。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号